Treatment.com AI Inc.
TRUE
CNSX
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | 85.71% | |||
| Gross Profit | 1,192.31% | -85.71% | |||
| SG&A Expenses | 232.52% | -14.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 228.21% | -14.22% | |||
| Operating Income | -213.98% | 14.22% | |||
| Income Before Tax | -190.76% | 13.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -190.76% | 13.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -190.76% | 13.37% | |||
| EBIT | -213.98% | 14.22% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -177.47% | 13.14% | |||
| Normalized Basic EPS | -187.13% | 13.30% | |||
| EPS Diluted | -177.47% | 13.14% | |||
| Normalized Diluted EPS | -187.13% | 13.30% | |||
| Average Basic Shares Outstanding | 4.62% | 0.00% | |||
| Average Diluted Shares Outstanding | 4.62% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
